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The adequacy of domiciliary non-invasive positive pressure ventilation (NIHV) for hypercapnic restrictive 
pulmonary disease in patients aged 75 years or above has been questioned, because of a lower life expectancy, a 
higher risk of neuropsychological impairment and a lower potential for adapting to NIHV. This study aims to 
illustrate that the use of NIHV is possible and efficient in this age group. 
In our referral area, all patients under NIHV have been included in a database since 1994; at the end of 1996, all 
patients in whom NIHV had been initiated at age 75 years or above were studied. We perfoqed a cross-sectional 
study of six patients (two men, four women, age: 79 7LI 3 years at time of study) who had been under NIHV for 
31 * 17 months. Patients underwent pulmonary function testing, assessment of respiratory muscle strength, physical 
disability and neuropsychological performance, tolerance and compliance to NIHV, and heath-related quality of life 
(SF-36, St. George Respiratory Questionnaire: SGRQ). Hospitalization rates were recorded for the year prior and 
the 2 yr following initiation of NIHV. 
By the time of the study, all patients showed improved arterial blood gases when compared to values before NIHV 
(PaCO,: 46 + 9 vs 66 + 10 mmHg, P=O.O4). Patients adapted well to NIHV, with minor side-effects and an average 
daily use of ventilator of 10.5 i 2 h. None of the patients showed signs of emotional disturbance. SF-36 scores for 
mental health, subjective well-being and vitality, or social functioning, did not differ, from that of age-matched 
controls. SGRQ scores were similar to those published for younger patients under .NIHV. Use of health care 
facilities was similar to that of younger patients under NIHV; hospitalization rates decreased significantly after 
initiating NIHV (40 & 31 days for year before NIHV, vs 13 + 14 days and 0.8 rt 0.4 days for the 2 yr following 
NIHV, P=O.O2). 
Age above 15 years should not be considered per se as a contraindication to NIHV in patients with well-accepted 
indications for this treatment. Our results suggest that in this age group, the cost/benefit ratio of NIHV may be 
favourable. 
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Introduction 
Since the early 1980s non-invasive home ventilation 
(NIHV) has become widely available in Europe and in 
North America. Currently accepted indications are mainly 
neuro-muscular diseases leading to alveolar hypo- 
ventilation, chest wall diseases such as kyphoscoliosis, 
restrictive lung diseases such as sequellae of tuberculosis 
(thoracoplasty, collapsotherapy) or severe bronchiectasis, 
and - although still subject to controversy - hypercapnic 
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chronic obstructive pulmonary disease (COPD) (14). In 
these indications, NIHV has been shown to improve 
blood gas values, exercise tolerance, and symptoms 
related to day-time hypercapnia (5). Quality of life of 
these patients has been described as satisfactory (1,6,7). 
However, the use of long-term NIHV in elderly patients 
(over 75 years of age) has been considered unreasonable. 
Reasons advocated are mainly a lower life expectancy in 
this age group, a higher risk of neuropsychological 
impairment, and a lower potential for adapting to the 
burden of NIHV (8,9). 
One study has focused on the quality of life of older 
patients receiving either long-term oxygen therapy (LTOT) 
or NIHV; however, most of these patients were not older 
than 75 years of age, and were treated by LTOT only (10). 
We could not find any other study reporting on NIHV in 
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the elderly and assessing the specific problems that such 
patients encounter with this treatment. 
This study aims to show that use of NIHV in selected 
elderly patients is possible and efficient. In our referral area 
(nearly 900 000 inhabitants), all patients in whom NIHV 
had been instituted after 75 years of age were identified and 
studied. General clinical features of these cases are shown, 
as well as specific assessment of their pulmonary physi- 
ology, physical disability, psychological profile, tolerance 
and compliance to NIHV, and finally their health-related 
quality of life and the treatment-related burden in terms of 
health care facilities. 
Methods 
DATABASE 
Since 1994, all patients with NIHV in our referral area have 
been included in a database and followed prospectively. 
This database includes diagnoses, indication for NIHV, 
duration of NIHV, average use of ventilator, ventilator 
settings, oxygen flow: lung function tests, arterial blood 
gases with and without ventilator, anthropometric data, 
dyspnoea scores and scores for emotional disorders; 
information is recorded on ,Filemaker Proa 2.1 software 
(Claris Corporation, U.S.A.). All patients under NIHV 
included in the database undergo periodical, comprehensive 
evaluations at least once a year. By the end of 1996, we 
found that six out of 70 patients from this database had 
NIHV instituted after 75 years of age (Table 1). The present 
study is a cross-sectional evaluation of these six patients, 
i.e. all patients above 75 years of age. For the purpose of 
the present study, these 6 patients had a more extensive 
evaluation during their last examination. It included specifi- 
cally the following items:’ lung function tests, estimation 
of physical disability, screening for emotional disturb- 
ances and dementia, measuring tolerance to NIHV and 
health-related quality of life. 
LUNG FUNCTION TESTS 
Forced expiratory manoeuvres were recorded with a 
Vitalograph Alphas spirometer (Vitalograph Ltd, 
U.K.). Values recorded were the best of three consecutive 
manoeuvres, as recommended by the American Thoracic 
Society (ATS) standards (11). Predicted values were those 
published by the European Respiratory Society (12). 
Peak mouth pressures were measured with a Mouth 
Pressure Mete@ (Precision Medical Ltd, Pickering, North 
Yorkshire, U.K.): peak inspiratory pressure (Prmax) was 
measured at residual volume, and peak kxpiratory pressure 
(PEmax) was measured at total lung capacity. Three to six 
manoeuvres were performed with a goal of the highest two 
matching within 10%. Data were discarded if the pressure 
was held for less than 1 s (13). Predicted values were those 
published for normal Swiss elderly subjects by Uldry et al. 
(in cmH,O): for Prmax: 90 & 2.5 for men, 67 & 17 for 
women; for PEmax: 118 f 39 for men, 79 & 21 for women 
(14). Arterial blood gases (ABL 330a”, Radiometer, 
Denmark) were measured by puncture of the radial artery, 
under room air after at least 6 h without NIHV, and under 
nasal ventilation after one night of NIHV. Values prior to 
initiation of NIHV were recorded and compared with 
present values. 
Resting dyspnoea was estimated by the patient with a 
Borg scale which ranged from 0 to 10, higher values 
indicating more severe dyspnoea (15). 
ESTIMATION OF PHYSICAL DlSABILITY 
A 6-min walk test was performed, as described by McGavin 
et al. (16). 
The oxygen cost diagram was used to quantify the 
effort above which patients thought their breathlessness 
would not allow them to go on, ranging from 0 (maximal 
impairment) to 100 (no impairment) (17). 
The level of performance in daily activities was assessed 
with a Karnofsky performance score. Scores for Karnofsky 
range O-10: 24, patients with severe handicap: needing 
assistance equivalent to that dispensed by a hospital; 5-7, 
varying degrees of assistance needed; 28, patients capable 
of maintaining a regular extra-domestic activity. 
SCREENING FOR EMOTIONAL DISTURBANCES 
AND DEMENTIA 
Two questionnaires were used to screen for anxiety or 
depression. The ‘Hospital Anxiety and Depression’ (HAD) 
questionnaire contains 14 multiple choice questions; seven 
are oriented towards detection of anxiety disorders and 
seven towards detection of depression (18). The HAD 
questionnaire has been validated in French (19). The 
authors suggest scoring as follows: ~8: no evidence of 
depression; 8-10: suggestive of depression or anxiety; > 10: 
abnormal values with a high specificity for anxiety or 
depressive disorders. Because of the age of our patients, a 
specifically geriatric 30 question-score was included: the 
Geriatric Depression Scale (GDS) (20) which has been 
validated in French (21). Scoring is as follows: ~11: no 
evidence of depression; 1 l-20: borderline values; ~20: 
moderate or severe depression. 
To exclude dementia, we used the Mini Mental State 
Examination (MMSE): a brief, physician administered, 
examination of cognitive function. It screens orientation, 
memory; attention, naming, comprehension and praxis, 
and scores from 0 (lowest) to 30 (22). Scores above 23 are 
considered ‘normal’. 
TOLERANCE AND COMPLIANCE TO NlHV 
A 21-item questionnaire was designed to evaluate any 
discomfort related to NIHV: this questionnaire has been 
used for all patients under NIHV in our referral area. 
Scores of our patients could therefore be compared to those 
obtained by 78 identical questionnaires from 34 younger 
patients, aged 58 & 12 years (range: 19-74) who had 
been under NIHV for 38 & 22 months, 9 i 3 h day - * (23). 
This questionnaire explores problems occurring with the 
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ventilator (malfunction, alarms, maintenance), the interface 
(air leaks, nasal soreness, skin abrasion, conjunctivitis, 
rhinitis), and other ventilator-related discomforts (cough, 
dry mouth, abdominal distension, sleep disturbances, chest 
pain). Each item receives a score (04) describing the 
intensity of the discomfort generated, and whether or not 
NIHV had to be interrupted for less or more than 48 h. 
Compliance to NIHV was calculated through counters 
on ventilators (visiting nurses kept regular records of 
counters). 
HEALTH-RELATED QUALITY OF LIFE (HRQL) 
The SF-36 (Short form-36) is a generic instrument for 
evaluating HRQL (24,25); it has been recently validated in 
French (26). It measures nine different health concepts. 
‘Physical functioning’ describes the extent to which health 
interferes with activities such as bathing, dressing, shop- 
ping, walking, climbing stairs. ‘Role physical’ and ‘Role 
emotional’ quantify the extent to which health interferes 
with daily activities because of physical or emotional prob- 
lems. ‘Bodily pain’ scores for the extent of bodily pain over 
the past 4 weeks. ‘Vitality’ quantifies subjective well-being 
(energy or tiredness). ‘Social functioning’ describes the 
extent to which health interferes with social activities such 
as visiting with friends or relatives during the preceding 
month. ‘Mental health describes the general mood of 
affect, including depression, anxiety and psychological well- 
being during the past month. ‘General health’ is an overall 
rating of current health in general (27). A database of 
normal values has been published for the U.S. population, 
by sex and age group (27); reference values are also 
available for the French population, by sex and age group 
W. 
The St. George Respiratory Questionnaire (SGRQ) is a 
disease-specific HRQL measurement instrument oriented 
towards chronic respiratory impairment, which contains 76 
items divided into three sections: ‘Symptoms’ relates to 
respiratory symptoms, their frequency and severity; 
‘Activity’ relates to activities that cause or are limited by 
breathlessness; and ‘Impacts’ covers social functioning and 
psychological disturbances resulting from respiratory dis- 
ease (29). A database of SGRQ scores for normal subjects 
without any history of respiratory disease (n=74, mean age: 
74, range: 17-80, FEV,: 95% of predicted) is supplied by the 
authors of the SGRQ. Reference values for normal subjects 
are given (see Table 5). Higher scores are related to 
increasing impairment or severity of symptoms (range: 
o-100). The SGRQ has been recently validated in French 
by Bouchet et al. (30). Although initially designed for 
patients with chronic airway disease, it has also been used 
for patients with predominantly restrictive diseases under 
NIHV (31). 
HOSPITALIZATION RATES BEFORE AND AFTER 
NIHV 
The total number of days spent in hospital were recorded 
for the year before initiation of NIHV, and the period of 
follow-up. All hospitalizations in the public hospitals of the 
canton of Geneva are recorded in a computerized database: 
this database was consulted to determine precisely the 
number of days per year spent in a hospital. 
EQUIPMENT (SEE TABLE 2) 
Five patients were equipped with a volumetric ventilator 
(Lifecarea PLV 100, Lifecare, U.S.A. or EoleD II A, Saime 
S.A.: France), and one with a pressure-support ventilator 
(BiPAP@, Respironics Inc., U.S.A.). Choice of a volumetric 
vs a barometric ventilator was based on patient’s comfort 
and correction of arterial PaCO,. Ventilator settings are 
given in Table 2; peak pressures did not exceed 25 cmH,O 
except when using custom-made masks that increase resist- 
ance to airflow (32). Four patients received oxygen sup- 
plementation during NIHV. The patients were equipped 
with commercially available nasal masks (Respironics Inc., 
U.S.A.) and custom-moulded masks (SEFAM: France) to 
be able to modify pressure points in the event of skin 
lesions. 
FACILITIES 
Supporting facilities for home treatment included 
regular home visits by a specialized nurse (average: every 
2 months). The nurses ask for signs of recent infection, or of 
car pulmonale. They also check pulse rate, blood pressure, 
SaO, by pulse oxymetry (Persona 0, lla, Micromed, 
Labhardt AC; Switzerland), FEV, and FVC with a port- 
able spirometer (Microspirometera, Micro Medical Ltd, 
England), and dyspnoea (Borg score). They recorded 
ventilator counters to assess for compliance, and check 
filters, masks, and tubing. In addition, there are semestrial 
or annual check-ups at the outpatient puhnonary clinic of a 
University Hospital. Two patients had weekly physical or 
chest therapy at home, and one patient had twice-weekly 
visits by a non-specialized registered nurse for general care. 
STATISTICS 
Because of the small size of the study group, non- 
parametric statistics were used. Wilcoxon’s signed-rank test 
was used to compare results in the same individuals. 
Mann-Whitney’s rank-sum test was used to compare 
data between groups consisting of different indi- 
viduals. Friedman’s test was used to compare repeated 
measurements in the same individuals. 
Results 
PATIENTS 
The six patients were two men and four women. Age at time 
of initiation of NIHV (i.e. between April 1992 and June 
1995) is given in Table 1. At the time of the present study, 
patients were 79 i 3 years of age, and had been using NIHV 
for 3 1 & 17 months (range: 17-55). Indications for NIHV in 
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TABLE 1. Age at which NIHV was started, duration of NIHV, average daily use of ventilator, and 
indication for NIHV 
Patient 
no. 
Age at Time under 
start of NIHV 
NIHV (7) (months) 
Hours of 
NIHV 
per 24 h Indication for NIHV 
1 75 33 11 Post-tuberculosis*; bronchiectasis 
2 75 18 I Post-tuberculosis* 
3 75 43 12 Obesity-hypoventilation 
4” 75 55 12 Post-tuberculosis* 
5 85 17 9 Post-tuberculosis* 
6 75 24 12 Kyphoscoliosis; post-polio syndrome 
*Restrictive or mixed pulmonary disease post-tuberculosis (with or without collapsotherapy). 
TNIHV: Non-invasive home ventilation. 
TABLE 2. Ventilators and ventilator settings at time of study 
Patient 
no. Ventilator Mode 
Tidal volume 
(1) RR I/E 
Oxygen flow 
(lmin-‘) 
1 Eole 2 A C 0.7 25 2 1.5 
2 Lifecare PLV 100 C 0.8 19 1.5 1 
3 BiPAP AC 20-6* 18 0 
4 Lifecare PLV 100 C 0.8 24 1.3 1.5 
5 Lifecare PLV 100 AC 0.45 25’ 1 1.5 
’ 6 Lifecare PLV 100 AC 0.6 18 1.5 0 
RR, Respiratory rate; C, controlled mode; AC, assist-control mode. 
*Inspiratory (IPAP) and expiratory (EPAP) pressure settings (cmH,O) for barometric ventilation. 
these patients were hypercapnic respiratory failure related 
to post-tuberculosis restrictive lung disease (n = 3), sequellae 
of poliomyelitis with severe kyphoscoliosis (n= l), obesity- 
hypoventilation syndrome (12 = 1) and severe bronchiectasis 
(n= 1). 
Co-morbidities were systemic hypertension (n=4), obes- 
ity (n=l), benign prostatic hypertrophy (n= l), and left 
ventricular dysfunction (n = 1). 
In all cases, presenting symptoms were progressive dysp- 
noea, fatigue, and somnolence. It is noteworthy that two 
cases presented with acute delirium in addition to the 
above-mentioned symptoms. Four cases had signs of 
decompensated car pulmonale with progressive weight 
gain, oedema of lower limbs, and distended jugular veins. 
All cases responded clinically to NIHV, with improve- 
ment of signs of right heart failure, dyspnoea, fatigue, 
somnolence, and disappearance of delirium. Length of 
hospital stay ranged from 12 to 90 days (median: 30 days), 
although in all cases adaptation to NIHV was satisfactory 
within the first 10 days. 
Five patients were married, one was a widower; five lived 
at their home, and were independent for basic activities of 
everyday life; one patient with a body-mass mdex of 
50 kg m- 2 lives in a long-term care institution, with her 
husband. 
LUNG FUNCTION TESTS 
Results of spirometry before initiation of NIHV and at the 
time of study are given in Table 3(a). There was a significant 
improvement in FEV, (PzO.04) and in FVC (P=O.O4). 
Fig. 1 and Table 3(b) show the evolution of arterial blood 
gases. 
When compared with values before NIHV, PaCO, values 
improved at time of study both on and off ventilator 
(P=O.O4). There was no significant difference between 
arterial blood gases on and off ventilator (P= 0.06 for PaO,, 
P=O.22 for PaCO,) at time of study. 
Inspiratory and expiratory mouth pressures (Prmax and 
Pnmax) were obtained only at time of study. They were 
clearly below normal values for this age group; values for 
Prmax were: 50 &X 26 cmH,O (range: 21-80) or 68 f 34% of 
predicted; values for PEmax were: 52 + 16 cmH,O (range: 
28870) or 58 f 21% of predicted (14). 
Borg scores (1 & 2, range: O-4) indicated that the patients 
had only a very slight resting dyspnoea. 
ESTIMATION OF PHYSICAL DISABILITY 
Results of 6-min walk tests were 335 ct 85 m (range: 2466 
425). ‘Oxygen cost diagram’ scores (43 f 13, range: 32-66) 
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TABLE 3(a). Pulmonary function tests before initiating NIHV and at time of study (expressed as % 
of predicted) 
Before initiating NIHV After initiating NIHV 
Patient FEV, FVC FEVJFVC FEV, FVC FEVJFVC 
1 45 40 127 51 52 109 
2 35 39 100 68 61 122 
3 25 23 42 29 44 69 
4 18 19 96 54 62 97 
5 35 45 90 39 41 99 
6 33 36 46 33 53 53 
Mean 32 34 84 46" 52" 92 
SD 9 10 33 15 9 26 
FEV,, Forced expiratory volume in 1 s; FVC, forced vital capacity; NIHV, non-invasive home 
ventilation. 
*Wilcoxon’s test comparing values before and after NIHV: P=O.O4. SD: standard deviation. 
TABLE 3(b). Arterial blood gas values before initiating NIHV, and at time of study, with and without 
ventilator. Values of PaCO, and PaO, are in mmHg 
After NIHV After NIHV 
Before NIHV without ventilator (with ventilator) 
Patient pH PaO, PaCO, pH PaO, PaCO, pH PaO, PaCO, 
1 7.34 53 65 7.47 64 38 7.50 77 40 
2 7.26 42 72 7.42 81 46 7.42 70 46 
3 7.34 30 76 7.39 59 49 7.48 74 33 
4 7.42 44 47 7.39 40 54 7.43 69 48 
5 7.30 67 71 746 82 33 7.52 96 30 
6 7.34 46 64 7.39 48 57 7.40 60 57 
Mean 7.33 47 66 7.42'" 62 46" 7.46" 74" 42” 
SD 0.05 12 10 0.04 17 9 0.05 12 10 
SD, standard deviation. 
*Wilcoxon’s test comparing values before and after initiating NIHV: PcO.05. 
showed that most patients could walk slowly on the level, 
but would become dyspnoeic either by carrying light 
weights, or by walking at a normal pace. 
The Karnofsky performance scores (Table 4) indicated 
that only one patient was severely disabled with a score of 
4. All the other patients needed little help in their everyday 
life. 
SCREENING FOR EMOTIONAL DISTURBANCES 
AND DEMENTIA 
Table 4 shows individual values for scores related to 
emotional disturbance, dementia and physical autonomy. 
Hospital anxiety and depression scores were within normal 
values with one single patient having a borderline score (8) 
for anxiety. Similarly, the geriatric depression scale did not 
reveal any score suggestive of definite depression; however: 
two patients showed borderline values of 14 and 20. Values 
for Mini Mental State test were within normal values for all 
patients. 
TOLERANCE AND COMPLIANCE TO NIHV 
The five most frequent causes of discomfort mentioned 
were: nasal soreness (five patients), discomfort related to air 
leaks (four patients), dryness of the nasal mucosa (five 
patients), abdominal distention (three patients), and sleep 
disturbances (four patients). When compared to results 
obtained in a younger population under NIHV, only nasal 
soreness (P=O.OOl) and discomfort related to air leaks 
(P=O.O14) were more frequent in the study group (data not 
shown). However, none of these items was important 
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Before Present data Present data 
NIHV w/o ventilator WI ventilator 
FIG. 1. Arterial blood gases before initiation of NIHV, 
and present data without NIPPV and with NIPPV. 
*Wilcoxon’s test for PaCO,. w, With ventilator; w/o, 
without ventilator. (O), PaO,; (0), PaCO,. 
enough to necessitate even a temporary interruption of 
NIHV. 
Average daily use of ventilators was 10.5 * 2 h 
(mean f SD) with a range of 7 to 12 h day - ‘. 
HEALTH RELATED QUALITY OF LIFE 
Figure 2 shows the mean scores of our six patients for each 
individual item of the SF-36 questionnaire, together with 
the mean scores of a French reference population (28) and 
of a U.S. reference population (27) of the same age, i.e. 
75585 years old. The item ‘Physical functioning’ scored 
significantly worse in patients studied than in both refer- 
ence populations, and scores for item ‘General health’ 
were lower than those of the French reference popu- 
lation (P~O.0001 for ‘physical functioning’, and P=O.O2 
40 
20 
0 
PF RP PI VT GH RE SF MH 
FIG. 2. SF-36 scores obtained in the present study (W), in 
a French reference population [O, (28)] and a U.S. refer- 
ence population [I$ (27)]. Values are expressed as 
mean f SEM. PF, physical functioning; RP, role physical; 
PI, pain index; VT, vitality; GH, general health; RE, role 
emotional; SF, social functioning; MH, mental health. 
Mann-Whitney rank-sum test: *P=O.O2, **P<O.OOOl. 
for ‘general health’). This is not surprising, since patients 
studied had severe respiratory impairment. However, for 
items ‘Role emotional’, ‘Role physical’, ‘Vitality’, ‘Social 
functioning’ and ‘Mental health’, there was no significant 
difference between patients studied and scores obtained in 
both reference populations. Scores for item ‘Bodily pain’ 
were in fact better than reference values for age-matched 
individuals (P=O.O2). 
Table 5 shows the results of the SGRQ scores. All values 
show a major impairment in terms of severity of symptoms, 
limitation in activities of everyday life, and psychosocial 
impact, when compared to younger healthy indi- 
viduals. The most severe limitation concerns the impact of 
breathlessness on everyday life activities. 
TABLE 4. Scores for emotional disturbances, dementia, and performance 
Patients 
Mini 
Mental 
State 
Examination 
(MMSE) 
Hospital Anxiety and 
Depression Questionnaire 
Anxiety Depression 
Geriatric Karnofsky 
Depression performance 
Scale score 
1 29 5 2 7 7 
2 30 5 4 4 8 
3 28 8 6 9 7 
4 25 4 1 14 4 
5 30 5 5 20 7 
6 30 3 3 8 7 
Mean 29 4.8 3.5 10 6.7 
SD 2 2.2 1.9 5.8 1.4 
SD, Standard deviation. See text for reference values. 
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TABLE 5. Results of St. George’s Respiratory Questionnaire (SGRQ) in present study, and in 
reference (31). ‘Normal values’ refer to values given by authors of the SGRQ (see text for details) 
Range of 
normal values 
Present study 
Mean SD 
Carone et al. 
Mean SD 
Number of cases 74 6 31 
Age 
FEV, (% predicted) 
Scores for: 
‘Symptoms’ 
‘Activity’ 
‘Impacts’ 
‘Total’ 
17-80 79 64 
95 45 14 39 15 
9-15 48 9 39 25 
7-12 71 19 67 17 
l-3 40 14 44 22 
5-l 51 12 50 18 
HOSPITALIZP;TION RATES BEFORE AND AFTER 
NIHV ’ 
A significant’decrease (Friedman’s test, P=O.O2) was noted 
in hospitalization rates for all six patients before and after 
NIIIV: 40 * 31 days (mean * SD) (range: 12-99 days) for 
the year ‘before NIHV, 13 i 14 (O-31 days) for the year 
after initiating NIHV, and 0.8 f 0.4 (0-l days) for the 
second year after initiation of NIHV. Four patients have 
not been hospitalized since NIHV was instituted; one 
patient was hospitalized for elective parenteral anti- 
biotherapy because of bronchiectasis (31 days);, one patient 
was hospitalized because of left heart failure and acute 
bronchitis (19 days). 
Discussion 
The present study describes six patients in whom home 
mechanical ventilation was initiated and pursued after 
75 years of age for 31 f 17 months. In spite of advanced 
age, patients adapted well to NIHV, with minor side-effects, 
and compliance to treatment was satisfactory; NIHV had a 
positive and significant effect on arterial blood gases and 
this effect persisted for several hours after interruption of 
NIHV; changes in PaO, however cannot be ascribed to 
NIHV alone, since four out of six patients also received 
oxygen therapy at various rates (Table 2). Use of health 
care facilities was similar to that of your&i patients under 
NIHV; hospitalization rates de&e&d signifi~an‘tly after 
initiating NIHV. Major emotional disturbances were not 
present in this group of patients. Quality-of-life scores for 
emotional disorders, subjective well-being and vitality, 
social functioning and mental health did not differ from 
those of age-matched reference populations. 
Amongst the well-accepted indications for NIHV, two 
groups of patients are ageing: those who suffered from 
poliomyelitis during the last epidemic in Europe and North 
America, (1955-1959) and those who suffered from 
sequelae of severe tuberculosis or collapsotherapy,,. just 
before the advent of,speci;fiC. antibiotherapy. In 1996, in 
France; 32 730 patients were,either under long-term oxygen 
therapy (LTOT) or home ventilatory support, of which 
7448 (23%) were over 75 years of age. Among patients over 
75 years of age under LTOT, 19% (1330) suffered from 
restrictive respiratory disorders; half of these patients were 
hypercapnic (33). These figures suggest that the occurrence 
of chronic hypercapnic respiratory insufficiency in patients 
over 75 years of age with restrictive disorders is not such a 
rare occurrence. 
In 1990, 46 patients were.nnder NIHV in Switzerland; 
none were over 70 years of age (8). As of September 1995, 
the number of patients had increased to 229; of these, 75 
were over 65 years of age (32%); 28 (12%) were over 70. 
However, only seven patients (3%) were over 75 years .of 
age (34). 
Inclusion criteria for the present study was initiation of’ 
NIHV at 75 years or above. The six patients of the present 
study represent all patients fultilling this criteria of age in 
our database. There was no selection of the ‘best cases’. 
However, it must be recognized that none of these patients 
suffered of any major co-morbidity, including depression or 
dementia. One may conclude that physicians in charge of 
such cases, in our referral area, probably did some form, 
of selection before deciding on NIHV with people tover.> 
75 years of age. Guidelines for NIHV have been publishe,d, 
by the Swiss Thoracic Society, but they do not give specific 
recommendations for the elderly. The results, of our study 
suggest that this may not be necessary, and that consider- 
atjons based on common sense criteria for prescribing 
NIHV in this age group might be,sufficient. c r c 
Equipment and use of health care facilities in patients 
studied was quite similar to that of younger subjects under 
NIHV: regular visits - every 2 months ~ by, a specialized 
nurse as for most patients under NIHV or LTOT in our 
referral area, and semestrial or annual check-ups at the 
outpatient pulmonary clinic of a University Hospital. Two 
patients had weekly physical or chest therapy at home, and 
one patient had twice-weekly visits by a registered nurse. 
For most patients however, active involvement of spouse 
and other family members played an important part in the 
success of their treatment. 
As, previously stated, the risk of developing a neuro- 
psychological impairment rises with age: according to 
Muller and Wertheimer, there is a 2.9% prevalence of 
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dementia before 75 years of age, which rises to 5.6% after 
75, and 22% after the age of 80 (35). Screening for dementia 
is mandatory in this age group before starting NIHV, and 
represents a clinical difhculty particularly in patients pre- 
senting with delirium as *.a manifestation of respiratory 
failure. This was the case for two of the patients studied; 
subsequent results of MMSE testing, after correction of 
arterial blood gases, were within normal limits, and these 
patients adapted well to NIHV. Patients presenting with 
delirium (or acute confusional episodes) are however at 
higher risk of functional decline within the following 
6 months (36) and have a higher rate of transfer to 
long-stay care institutions (37). 
Tolerance scores revealed frequent air leaks and nasal 
soreness (related to pressure of masks); other frequent 
complaints were dryness of the nasal or pharyngeal mucosa, 
abdominal distension, and sleep disruption; none of these 
problems was severe enough to necessitate even a tempor- 
ary interruption of NIHV. The alternate use of two differ- 
ent nasal masks per patient (i.e. one custom-made andlone 
commercially available) diminished the incidence of skin 
lesions. Mucosal dryness responded to air humidification. 
Abdominal distension disappeared when adjusting ventila- 
tor settings in order to diminish peak pressures. Complaints 
related to sleep disruption tended to diminish with time. 
Certain difficulties arising during initiation of NIHV were 
most probably age-related: delirium induced by hyper- 
capnia upon initial admission, air leaks due to thin soft 
tissues in patients suffering from malnutrition, pain or 
mucosal lesions related to pressure of mask on dentures, 
initial apprehension related to the apparatus. At initiation 
of treatment, all patients were able to adapt to NIHV 
within lo-15 days and return home after a mean hospital 
stay of 38 days (range: 12-90). 
The major therapeutic goal when considering NIHV in 
elderly patients is maintaining - or improving ~ quality of 
life. Published data as to the impact of NIHV on quality of 
life are available for younger subjects. Pehrsson et al. (7) 
described the quality of life of 39 patients under home 
imechanii@ ventilation, aged 17-74 years, and reported 
satisfactory levels of both psychosocial functioning and 
mental wellbeing. Scores for psychosocial functioning and 
for emotional disorders did not differ significantly between 
patients and normal reference groups. Physical function 
however was poor, due to limitations in mobility and 
a:tivities of daily life. Goldstein et al. (38) used an open- 
ended questionnaire to evaluate 98 home mechanical ven- 
tilation users aged 47 I-t 19 years: 87% of the patients 
described the impact of using a mechanical ventilator as 
‘overwhelmingly positive’, with a positive impact on physi- 
cal symptoms and mobility. In the present study, the SF-36 
was used as a generic qualitx&-life questionnaire (39). 
Scores for mental health, psychological and social function- 
ing, and vitality were similar to, those of representative 
samples of age-matched normal populations, although 
scores for physical functioning and general health were 
significantly worse (Fig. 2). Results of the St. George’s 
Respiratory Questionnaire (a disease-specific questionnaire) 
were similar to those obtained in younger subjects by 
Carone et al. (31), who described the quality of life of 37 
patients aged 50-75 years under home mechanical ventila- 
tion (Table 5), and by Meecham-Jones (4) who analysed 14 
patients treated by pressure support nasal ventilation for 
hypercapnic COPD (mean age: 69, range: 43-74). Scores 
for ‘Symptoms’ and ‘Activities’ showed marked physical 
impairment, with lower (i.e. better) scores for ‘Impacts’, a 
section quantifying social functioning and psychological 
disturbances resulting from respiratory disease. Finally, 
scores for emotional disturbances (HAD and GDS) did not 
reveal any case of definite depression. 
The cost of treating elderly patients by NIHV is of course 
an important issue: do patients above 75 years of age cost 
more than younger subjects? Is NIHV in this age group 
cost-effective? In the present study, use of health care 
facilities and equipment was quite similar to that of 
younger subjects, and advanced age was not associated with 
more frequent home visits. The major burden in the care 
of patients with respiratory insufficiency is related to 
hospitalizations. Prevention of hospitalizations may there- 
fore be a major goal in terms of cost-effectiveness. A 
significant decrease was noted in hospitalization rates for all 
six patients when comparing the year before and the 2 yr 
after initiating’NIHV. In fact, four patients had not been 
hospitalized since NIHV was instituted; one patient with 
severe bronchikctasis was hospitalized for elective 
parenteral antibiotherapy, but did not suffer from any 
episode of acute cardiac or respiratory failure; only one 
patient had an acute kpisbde of cardiac and respiratory 
failure following a lower /respiratory tract infection, with a 
favourable outcome. ,,. . 
Between 1990 and 1996, fhe‘number of patients under 
NIHV in Switzerland has been’multiplied by five; further- 
more, the proportion of older patients is increasing: 32% of 
these patients are aged over 65 years. In the present study, 
we raised the question of the feasibility of NIHV in the 
‘very old’. We have shown that age above 75 years should 
not be considered per se as a contraindication to NIHV in 
patients with otherwise well accepted indications for NIHV. 
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